...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

instrAction and Protagen Form Strategic Alliance

| Print |
Tuesday, 15 March 2011 10:00 (UTC + 1)

Protagen_logo

Dortmund, Germany, March 15, 2011 / b3c newswire / - instrAction GmbH, Ludwigshafen, the specialist for design and production of selective separation matrices and Protagen AG, Dortmund, a GMP certified service laboratory for protein analysis signed a strategic alliance for the development of customized instrAction® Phases for downstream processing of biotherapeutics.

 

“The instrAction® Phases are proprietary synthetic chromatography phases which show excellent performance compared to commonly used matrices for e.g. antibody purification. The unique know-how and expertise of Protagen in GMP-compliant protein analysis and related services will be decisive for the development of a portfolio of new tailor made separation phases for the production of recombinant protein drugs, other biotherapeutics and biosimilars”, comments Dr. Thomas Schwarz, CEO of instrAction.

 

“In order to exploit the full value of this exciting new protein purification technology and to convince customers from pharma process development and production, it is important to provide convincing data sets from feasibility studies. Protagen has all the tools and know-how to support instrAction on its way to become the leading company in protein separation technology”, underscores Dr. Stefan Müllner, CEO of Protagen.

 

 

About Protagen AG - www.protagen.de

Protagen AG is an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis. The innovations of Protagen are UNIarray®, a technology platform for the development of novel serum based diagnostics, as well as UNIchip®, a versatile product family of protein microarrays for faster development of antibodies.

 

 

About instrAction GmbH - www.instraction.com 

instrAction, founded in 1997 and located at the BASF site in Ludwigshafen, develops and manufactures "instrAction® phases” as novel highly selective resins for chromatography. The proprietary technology enables the immobilization of a wide variety of functional ligands on a polymer network, coated on very different porous backbone materials. Small molecules as well as substances with high molecular weight are separated by highly selective reversible interactions. The high selectivity of an instrAction stationary phase is thereby reached by multivalent-multimodal interactions between target molecule and the functional ligands of the phase, similar to the lock-and-key principle.

 

 

Contact
Dr. Stefan Müllner
CEO
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund

Tel:   +49 (0) 231 9742 6300
Fax:  +49 (0) 231 9742 6301

E-Mail:  This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

Media Enquiries
Bettina Franz
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund

Tel:   +49 (0) 231 9742 6300
Fax:  +49 (0) 231 9742 6301

E-Mail:  This e-mail address is being protected from spambots. You need JavaScript enabled to view it